Assetmark »

Ernexa Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Ernexa Therapeutics shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2026-06-30 $33 5 6.60

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust St Bloo High Etf (JNK)

View all positions for Assetmark

Top funds holding Ernexa Therapeutics

Citadel Advisors
Vanguard Fiduciary Trust
Dauntless Investment Group
Vanguard Capital Management
Tradewinds Capital Management
BlackRock
Assetmark
Bnp Paribas Arbitrage, Snc
SBI Securities

View all funds holding Ernexa Therapeutics